Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant Therapy: A Comprehensive Meta-Analysis

Background: Neoadjuvant therapy (NAT) represents a paradigm shift in the management of patients with pancreatic ductal adenocarcinoma (PDAC) with perceived benefits including a higher R0 rate. However, it is unclear whether NAT affects the sites and patterns of recurrence after surgery. This review...

Descripción completa

Detalles Bibliográficos
Autores principales: Ratnayake, Bathiya, Savastyuk, Alina Y., Nayar, Manu, Wilson, Colin H., Windsor, John A., Roberts, Keith, French, Jeremy J., Pandanaboyana, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408905/
https://www.ncbi.nlm.nih.gov/pubmed/32640720
http://dx.doi.org/10.3390/jcm9072132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408905/
https://www.ncbi.nlm.nih.gov/pubmed/32640720
http://dx.doi.org/10.3390/jcm9072132

Ejemplares similares